Cargando…
Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes
BACKGROUND: Nano-sized vesicles, so called extracellular vesicles (EVs), from regenerative cardiac cells represent a promising new therapeutic approach to treat cardiovascular diseases. However, it is not yet sufficiently understood how cardiac-derived EVs facilitate their protective effects. Theref...
Autores principales: | Beez, Christien M., Haag, Marion, Klein, Oliver, Van Linthout, Sophie, Sittinger, Michael, Seifert, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537224/ https://www.ncbi.nlm.nih.gov/pubmed/31133024 http://dx.doi.org/10.1186/s12951-019-0504-0 |
Ejemplares similares
-
Cardiac Extracellular Vesicles (EVs) Released in the Presence or Absence of Inflammatory Cues Support Angiogenesis in Different Manners
por: Beez, Christien Madlen, et al.
Publicado: (2019) -
MiRNA Profiles of Extracellular Vesicles Secreted by Mesenchymal Stromal Cells—Can They Predict Potential Off-Target Effects?
por: Nazari-Shafti, Timo Z., et al.
Publicado: (2020) -
Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies
por: Diedrichs, Falk, et al.
Publicado: (2019) -
Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2011) -
Myocardial Regeneration via Progenitor Cell-Derived Exosomes
por: Maring, Janita A., et al.
Publicado: (2017)